🔗 Share this article

An underground market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Traction Online

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to message these accounts privately for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Additionally, a robust market exists on Telegram, where groups with thousands of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers promote the substance there before redirecting customers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Worries

Nevertheless, physicians and chemists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could result in individuals injecting substances of unknown origin.

Some experts stated the demand for the experimental drug could be connected to the rising cost of approved slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the British medical regulations.

Several influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach pharmaceutical, advertising, and consumer laws, risking fines, legal action or prison.

Platform Response and Material Removal

Based on TikTok, the platform has removed problematic content and prohibited associated hashtags and query recommendations. The company said it was dedicated to maintaining the platform safe and investing in enhancing compliance measures.

Online Marketplace Activities

Investigations also found groups with up to nine thousand members marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with numerous of members, populated with images of slimming results, glowing reviews and detailed guides for mixing or injecting at home.

After minutes of joining one group, a vendor shared contact information, where most purchases occur. The seller sent an guidebook and guaranteed shipping within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about weight, health issues or previous experience.

Product Details and Pricing

Within these communities, messages display black plastic packages with Royal Mail stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with sterile water, or pre-filled pens typically priced at £160 for 20 milligrams. When questioned how much time a pen should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for Telegram stated it regularly monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these digital versions may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in interest to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are using social media. But counterfeit injections are highly risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has already encountered patients injured by self-injection from unverified suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may subject users to potentially significant health risks”.